Download video

AACR 2023 highlights on advances in the neoadjuvant treatment of resectable NSCLC with John Heymach

1.8K views

European Society for Medical Oncology (ESMO)

1 year ago

AACR 2023 highlights on advances in the neoadjuvant treatment of resectable NSCLC with John Heymach

AACR 2023 highlights on advances in the neoadjuvant treatment of resectable NSCLC with John Heymach

AACR 2023 highlights on advances in the neoadjuvant treatment of resectable NSCLC with John Heymach
3:44
AACR 2023 highlights on advances in the neoadjuvant treatment of resectable NSCLC with John Heymach
by European Society for Medical Oncology (ESMO)
AACR 2023 highlights on advances in the treatment of resected high-risk melanoma with Jeffrey Weber
3:40
AACR 2023 highlights on advances in the treatment of resected high-risk melanoma with Jeffrey Weber
by European Society for Medical Oncology (ESMO)
AACR 2023 highlights on advances in the treatment of biliary tract cancer with Robin Katie Kelley
4:53
AACR 2023 highlights on advances in the treatment of biliary tract cancer with Robin Katie Kelley
by European Society for Medical Oncology (ESMO)
AACR 2023 highlights on advances in the treatment of hepatocellular carcinoma with Pierce Chow
3:29
AACR 2023 highlights on advances in the treatment of hepatocellular carcinoma with Pierce Chow
by European Society for Medical Oncology (ESMO)
Maximizing the Impact of EGFR-Targeted Therapy in Resectable NSCLC
43:35
Maximizing the Impact of EGFR-Targeted Therapy in Resectable NSCLC
by PeerView Oncology
ASCO 2023 Expert Report on novelties in oncogene driven NSCLC by A. Curioni-Fontecedro
4:47
ASCO 2023 Expert Report on novelties in oncogene driven NSCLC by A. Curioni-Fontecedro
by European Society for Medical Oncology (ESMO)
Neoadjuvant, Adjuvant, or Both: Individualized Perioperative Immunotherapy in Resectable NSCLC
48:44
Neoadjuvant, Adjuvant, or Both: Individualized Perioperative Immunotherapy in Resectable NSCLC
by PeerView Oncology
Expert report on neoadjuvant immune checkpoint inhibitors for NSCLC
7:00
Expert report on neoadjuvant immune checkpoint inhibitors for NSCLC
by European Society for Medical Oncology (ESMO)
Patients reportedly beating cancer with just one tablet a day | 9 News Australia
2:58
Patients reportedly beating cancer with just one tablet a day | 9 News Australia
by 9 News Australia
ASCO Daily News 2023 Plenary Update - LBA3: ADAURA
6:33
ASCO Daily News 2023 Plenary Update - LBA3: ADAURA
by ASCOcancer
AACR 2023 Recap with Dr. Christopher Klebanoff
5:55
AACR 2023 Recap with Dr. Christopher Klebanoff
by Cancer Research Institute
American Association for Cancer Research (AACR) 2023 Highlights from Community Oncology
8:38
American Association for Cancer Research (AACR) 2023 Highlights from Community Oncology
by OncBrothers: Practice-Changing Cancer Discussions
Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLC
43:46
Realizing the Promise of Perioperative Immunotherapy in Resectable NSCLC
by PeerView Oncology
Adherence \& outcomes of neoadjuvant immunotherapy in resectable NSCLC
0:58
Adherence \& outcomes of neoadjuvant immunotherapy in resectable NSCLC
by VJOncology
Precision Oncology in Early-Stage Lung Cancer, With Adjuvant EGFR-Targeted Therapy Leading the Way
59:19
Precision Oncology in Early-Stage Lung Cancer, With Adjuvant EGFR-Targeted Therapy Leading the Way
by PeerView Oncology
Advancements in targeted therapies for oncogene-driven resectable NSCLC
1:17
Advancements in targeted therapies for oncogene-driven resectable NSCLC
by VJOncology
Marking New Milestones With Immunotherapy in Locally Advanced and Early Lung Cancer
59:24
Marking New Milestones With Immunotherapy in Locally Advanced and Early Lung Cancer
by PeerView Oncology
Surgical perspective on neoadjuvant IO for resectable stage III NSCLC
6:37
Surgical perspective on neoadjuvant IO for resectable stage III NSCLC
by VJOncology
The latest trends in the management of oncogene-driven resectable NSCLC
1:04
The latest trends in the management of oncogene-driven resectable NSCLC
by VJOncology
Expert Video Report on featured outcomes from novel NSCLC trials @AACR 2022
4:26
Expert Video Report on featured outcomes from novel NSCLC trials @AACR 2022
by European Society for Medical Oncology (ESMO)
SQUAT: neoadjuvant chemo-immuno-radiation and surgery in NSCLC
1:31
SQUAT: neoadjuvant chemo-immuno-radiation and surgery in NSCLC
by VJOncology